2024-01-012024-12-312024-12-31false06766287LONDON MEDICAL ASSOCIATES LIMITED2025-09-25falseiso4217:GBPxbrli:pure067662872023-12-31067662872024-12-31067662872024-01-012024-12-31067662872022-12-31067662872023-12-31067662872023-01-012023-12-3106766287bus:SmallEntities2024-01-012024-12-3106766287bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3106766287bus:AbridgedAccounts2024-01-012024-12-3106766287bus:PrivateLimitedCompanyLtd2024-01-012024-12-3106766287core:WithinOneYear2024-12-3106766287core:AfterOneYear2024-12-3106766287core:WithinOneYear2023-12-3106766287core:AfterOneYear2023-12-3106766287core:ShareCapital2024-12-3106766287core:SharePremium2024-12-3106766287core:RevaluationReserve2024-12-3106766287core:OtherReservesSubtotal2024-12-3106766287core:RetainedEarningsAccumulatedLosses2024-12-3106766287core:ShareCapital2023-12-3106766287core:SharePremium2023-12-3106766287core:RevaluationReserve2023-12-3106766287core:OtherReservesSubtotal2023-12-3106766287core:RetainedEarningsAccumulatedLosses2023-12-3106766287core:LandBuildings2024-12-3106766287core:PlantMachinery2024-12-3106766287core:Vehicles2024-12-3106766287core:FurnitureFittings2024-12-3106766287core:OfficeEquipment2024-12-3106766287core:NetGoodwill2024-12-3106766287core:IntangibleAssetsOtherThanGoodwill2024-12-3106766287core:ListedExchangeTraded2024-12-3106766287core:UnlistedNon-exchangeTraded2024-12-3106766287core:LandBuildings2023-12-3106766287core:PlantMachinery2023-12-3106766287core:Vehicles2023-12-3106766287core:FurnitureFittings2023-12-3106766287core:OfficeEquipment2023-12-3106766287core:NetGoodwill2023-12-3106766287core:IntangibleAssetsOtherThanGoodwill2023-12-3106766287core:ListedExchangeTraded2023-12-3106766287core:UnlistedNon-exchangeTraded2023-12-3106766287core:LandBuildings2024-01-012024-12-3106766287core:PlantMachinery2024-01-012024-12-3106766287core:Vehicles2024-01-012024-12-3106766287core:FurnitureFittings2024-01-012024-12-3106766287core:OfficeEquipment2024-01-012024-12-3106766287core:NetGoodwill2024-01-012024-12-3106766287core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3106766287core:ListedExchangeTraded2024-01-012024-12-3106766287core:UnlistedNon-exchangeTraded2024-01-012024-12-3106766287core:MoreThanFiveYears2024-01-012024-12-3106766287core:Non-currentFinancialInstruments2024-12-3106766287core:Non-currentFinancialInstruments2023-12-3106766287dpl:CostSales2024-01-012024-12-3106766287dpl:DistributionCosts2024-01-012024-12-3106766287core:LandBuildings2024-01-012024-12-3106766287core:PlantMachinery2024-01-012024-12-3106766287core:Vehicles2024-01-012024-12-3106766287core:FurnitureFittings2024-01-012024-12-3106766287core:OfficeEquipment2024-01-012024-12-3106766287dpl:AdministrativeExpenses2024-01-012024-12-3106766287core:NetGoodwill2024-01-012024-12-3106766287core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3106766287dpl:GroupUndertakings2024-01-012024-12-3106766287dpl:ParticipatingInterests2024-01-012024-12-3106766287dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3106766287core:ListedExchangeTraded2024-01-012024-12-3106766287dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3106766287core:UnlistedNon-exchangeTraded2024-01-012024-12-3106766287dpl:CostSales2023-01-012023-12-3106766287dpl:DistributionCosts2023-01-012023-12-3106766287core:LandBuildings2023-01-012023-12-3106766287core:PlantMachinery2023-01-012023-12-3106766287core:Vehicles2023-01-012023-12-3106766287core:FurnitureFittings2023-01-012023-12-3106766287core:OfficeEquipment2023-01-012023-12-3106766287dpl:AdministrativeExpenses2023-01-012023-12-3106766287core:NetGoodwill2023-01-012023-12-3106766287core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3106766287dpl:GroupUndertakings2023-01-012023-12-3106766287dpl:ParticipatingInterests2023-01-012023-12-3106766287dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3106766287core:ListedExchangeTraded2023-01-012023-12-3106766287dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3106766287core:UnlistedNon-exchangeTraded2023-01-012023-12-3106766287core:NetGoodwill2024-12-3106766287core:IntangibleAssetsOtherThanGoodwill2024-12-3106766287core:LandBuildings2024-12-3106766287core:PlantMachinery2024-12-3106766287core:Vehicles2024-12-3106766287core:FurnitureFittings2024-12-3106766287core:OfficeEquipment2024-12-3106766287core:AfterOneYear2024-12-3106766287core:WithinOneYear2024-12-3106766287core:ListedExchangeTraded2024-12-3106766287core:UnlistedNon-exchangeTraded2024-12-3106766287core:ShareCapital2024-12-3106766287core:SharePremium2024-12-3106766287core:RevaluationReserve2024-12-3106766287core:OtherReservesSubtotal2024-12-3106766287core:RetainedEarningsAccumulatedLosses2024-12-3106766287core:NetGoodwill2023-12-3106766287core:IntangibleAssetsOtherThanGoodwill2023-12-3106766287core:LandBuildings2023-12-3106766287core:PlantMachinery2023-12-3106766287core:Vehicles2023-12-3106766287core:FurnitureFittings2023-12-3106766287core:OfficeEquipment2023-12-3106766287core:AfterOneYear2023-12-3106766287core:WithinOneYear2023-12-3106766287core:ListedExchangeTraded2023-12-3106766287core:UnlistedNon-exchangeTraded2023-12-3106766287core:ShareCapital2023-12-3106766287core:SharePremium2023-12-3106766287core:RevaluationReserve2023-12-3106766287core:OtherReservesSubtotal2023-12-3106766287core:RetainedEarningsAccumulatedLosses2023-12-3106766287core:NetGoodwill2022-12-3106766287core:IntangibleAssetsOtherThanGoodwill2022-12-3106766287core:LandBuildings2022-12-3106766287core:PlantMachinery2022-12-3106766287core:Vehicles2022-12-3106766287core:FurnitureFittings2022-12-3106766287core:OfficeEquipment2022-12-3106766287core:AfterOneYear2022-12-3106766287core:WithinOneYear2022-12-3106766287core:ListedExchangeTraded2022-12-3106766287core:UnlistedNon-exchangeTraded2022-12-3106766287core:ShareCapital2022-12-3106766287core:SharePremium2022-12-3106766287core:RevaluationReserve2022-12-3106766287core:OtherReservesSubtotal2022-12-3106766287core:RetainedEarningsAccumulatedLosses2022-12-3106766287core:AfterOneYear2024-01-012024-12-3106766287core:WithinOneYear2024-01-012024-12-3106766287core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3106766287core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3106766287core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3106766287core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3106766287core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3106766287core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3106766287core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3106766287core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3106766287core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3106766287core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3106766287core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3106766287core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3106766287core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3106766287core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3106766287core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3106766287core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3106766287core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3106766287core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3106766287core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3106766287core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3106766287core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3106766287core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3106766287core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3106766287core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3106766287core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3106766287core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3106766287core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3106766287bus:Director12024-01-012024-12-3106766287bus:Director22024-01-012024-12-3106766287bus:Director32024-01-012024-12-3106766287bus:Director42024-01-012024-12-3106766287bus:Director52024-01-012024-12-3106766287bus:Director62024-01-012024-12-3106766287bus:Director72024-01-012024-12-3106766287bus:Director82024-01-012024-12-31

LONDON MEDICAL ASSOCIATES LIMITED

Registered Number
06766287
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

LONDON MEDICAL ASSOCIATES LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Directors

ALI, Mohammed Akber, Dr
BOVILL, Elizabeth Sara
BUTLER, Fiona Ogilvie, Dr
DHANJAL, Parminder Kaur, Dr
JAYARAM, Nandana, Dr
KATZ, Naomi Esther, Dr
MCCARTHY, Deborah
YOUNG, Warwick

Registered Address

Ramsay Brown Llp The Brentano Suite
Solar House, 915 High Road
North Finchley
N12 8QJ

Registered Number

06766287 (England and Wales)
LONDON MEDICAL ASSOCIATES LIMITED
Balance Sheet as at
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets422,89428,733
22,89428,733
Current assets
Debtors53,772,1732,194,356
Cash at bank and on hand1,483,8621,732,866
5,256,0353,927,222
Creditors amounts falling due within one year6(4,070,441)(2,859,106)
Net current assets (liabilities)1,185,5941,068,116
Total assets less current liabilities1,208,4881,096,849
Net assets1,208,4881,096,849
Capital and reserves
Called up share capital231,762231,762
Share premium(49,041)(49,041)
Profit and loss account1,025,767914,128
Shareholders' funds1,208,4881,096,849
The financial statements were approved and authorised for issue by the Board of Directors on 25 September 2025, and are signed on its behalf by:
BUTLER, Fiona Ogilvie, Dr
Director
Registered Company No. 06766287
LONDON MEDICAL ASSOCIATES LIMITED
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Office Equipment4
2.Average number of employees

20242023
Average number of employees during the year118110
3.Prior period adjustment
A prior year adjustment and a restatement of comparatives figures have been made to correct the classification of an advance payment for share buyback from shareholders. The effect on the financial statements for the year ended 31 December 2023 are as follows: Balance sheet: Other debtors increased by £169,410 Share capital increased by £3,900 Other reserves decreased by £163,800 Retained earnings increased by £1,710 Profit and loss: External consultant decreased by £675 Stamp duty decreased by £1,035 Net profit increased by £1,710 The net effect of the above comparative adjustment has increased retained earnings and corporation tax liability by £1,710 and £159 respectively.
4.Tangible fixed assets

Total

£
Cost or valuation
At 01 January 2458,229
Additions9,969
At 31 December 2468,198
Depreciation and impairment
At 01 January 2429,495
Charge for year15,809
At 31 December 2445,304
Net book value
At 31 December 2422,894
At 31 December 2328,733
5.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables2,153,2471,573,834
Other debtors321,105213,910
Called up share capital not paid, current asset10,65410,654
Prepayments and accrued income1,287,167395,958
Total3,772,1732,194,356
6.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables836,342741,528
Taxation and social security36,51360,961
Other creditors1,619,510637,376
Accrued liabilities and deferred income1,578,0761,419,241
Total4,070,4412,859,106